Phase II trial of neoadjuvant docetaxel and gefitinib followed by radical prostatectomy in patients with high-risk, locally advanced prostate cancer

Jacqueline Vuky, Christopher Porter, Christina Isacson, Matthew Vaughan, Paul Kozlowski, Vincent Picozzi, John Corman

Research output: Contribution to journalArticle

36 Scopus citations

Fingerprint Dive into the research topics of 'Phase II trial of neoadjuvant docetaxel and gefitinib followed by radical prostatectomy in patients with high-risk, locally advanced prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences